Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

  • Biotechnology
  • Chemicals
  • Food processing
  • Electronics
  • Healthcare
  • Pharmaceuticals


Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

  • Market segmentation
  • Competitive landscape
  • Regulatory policies
  • Latest technology trends
  • Acquisition evaluations
  • Vendors’ analysis, etc.
Publications found: 60,074
Sort by:

2014 Analysis of Sexually-Transmitted Diseases in the UK: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

November 2013 280 pages

2014 Analysis of Sexually-Transmitted Diseases in the US: Market Outlook and Emerging Opportunities

US$ 2,760.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

November 2013 280 pages

2014 Analysis of Transfusion Diagnostic Instrumentation and Strategic Profiles of Leading Suppliers

US$ 2,800.00

This new 68-page report from Venture Planning Group reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic ...

November 2013 68 pages

2014 Analysis of Enteric Diseases in France: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Germany: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Italy: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Japan: Market Outlook and Emerging Opportunities

US$ 2,080.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Spain: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in the UK: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in the US: Market Outlook and Emerging Opportunities

US$ 3,080.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Respiratory Diseases in France: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 282 pages

2014 Analysis of Respiratory Diseases in Germany: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 283 pages

2014 Analysis of Respiratory Diseases in Italy: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

November 2013 281 pages

2014 Analysis of Respiratory Diseases in Japan: Market Outlook and Emerging Opportunities

US$ 1,920.00

About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

November 2013 282 pages

2014 Analysis of Respiratory Diseases in Spain: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

November 2013 281 pages

2014 Analysis of Respiratory Diseases in the UK: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 281 pages

2014 Analysis of Respiratory Diseases in the US: Market Outlook and Emerging Opportunities

US$ 2,880.00

About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 283 pages

2014 Analysis of the French Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 508 pages, 67 tables and presents a comprehensive analysis of the French hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 508 pages

2014 Analysis of the German Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 523 pages

2014 Analysis of the Italian Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 521 pages, 63 tables and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 521 pages

2014 Analysis of the Japanese Hospital Clinical ChemistryAnd Immunodiagnostics Market

US$ 3,880.00

This new report from Venture Planning Group contains 520 pages, 64 tables and presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 520 pages

2014 Analysis of the Spanish Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 514 pages, 63 tables and presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 514 pages

2014 Analysis of the UK Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...

November 2013 523 pages

2014 Analysis of the US Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 6,240.00

This new report from Venture Planning Group contains 543 pages, 63 tables and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...

November 2013 543 pages

2014 Analysis of the US Hospital Infectious Disease Testing Market

US$ 5,440.00

This new report from Venture Planning Group contains 997 pages, 87 tables and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 997 pages

2014 Analysis of the French Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 897 pages, 77 tables and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 897 pages

2014 Analysis of the German Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 897 pages, 74 tables and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 897 pages

2014 Analysis of the Italian Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 887 pages, 72 tables and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social ...

November 2013 887 pages

2014 Analysis of the Japanese Hospital Infectious Disease Testing Market

US$ 4,640.00

This new report from Venture Planning Group contains 891 pages, 75 tables and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social ...

November 2013 891 pages

2014 Analysis of the Spanish Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 880 pages, 73 tables and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social ...

November 2013 880 pages

2014 Analysis of the UK Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 886 pages, 67 tables and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 886 pages

2014 Analysis of Blood Typing, Grouping and Screening Tests, and Strategic Profiles of Leading Suppliers

US$ 2,800.00

This new 225-page report from Venture Planning Group presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of ...

November 2013 225 pages

2014 Analysis of the French Hospital Tumor Marker Testing Market

US$ 3,080.00

This new report from Venture Planning Group contains 533 pages, 43 tables and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 533 pages

2014 Analysis of the German Hospital Tumor Marker Testing Market

US$ 3,080.00

This new report from Venture Planning Group contains 530 pages, 40 tables and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 530 pages

2014 Analysis of the Italian Hospital Tumor Marker Testing Market

US$ 3,080.00

This new report from Venture Planning Group contains 525 pages, 38 tables and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 525 pages

2014 Analysis of the Japanese Hospital Tumor Marker Testing Market

US$ 3,880.00

This new report from Venture Planning Group contains 537 pages, 42 tables and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 537 pages

2014 Analysis of the Spanish Hospital Tumor Marker Testing Market

US$ 3,080.00

This new report from Venture Planning Group contains 521 pages, 41 tables and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 521 pages

2014 Analysis of the UK Hospital Tumor Marker Testing Market

US$ 3,080.00

This new report from Venture Planning Group contains 527 pages, 37 tables and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

November 2013 527 pages

2014 Analysis of the US Hospital Tumor Marker Testing Market

US$ 5,200.00

This new report from Venture Planning Group contains 567 pages, 50 tables and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...

November 2013 567 pages

2014 Analysis of Leading Cancer Diagnostic Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 2,000.00

This new report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product ...

November 2013 80 pages

2014 Analysis of Leading Coagulation Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 2,000.00

This new report from Venture Planning Group provides strategic assessments of major coagulation product suppliers and emerging market entrants. The report presents analyses of major manufacturers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, ...

November 2013 45 pages

2014 Analysis of Leading Hematology and Flow Cytometry Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

This new report from Venture Planning Group provides strategic assessments of major suppliers of hematology and flow cytometry instuments and reagants, as well as emerging market entrants. The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product ...

November 2013 30 pages

2014 Analysis of Leading Hemostasis Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 2,000.00

This new report from Venture Planning Group provides strategic assessments of major suppliers of hemostasis diagnostic products, as well as emerging market entrants. The report presents analyses of major current and emerging suppliers of hemostasis instruments ans reagents, including: Sales estimates ...

November 2013 45 pages

2014 Analysis of Leading Infectious Disease Market Players--Insightful Profiles of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

... new report from Venture Planning Group provides strategic assessments of major suppliers of infectious deisease instuments and reagants, as well as emerging market entrants. The report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products ...

November 2013 90 pages

2014 Analysis of Leading Life Science Intermediates Companies Technological Know-How

US$ 1,960.00

This new report from Venture Planning Group provides technological know-how of leading life science intermediates companies. The report presents: Internally developed and acquired technologies, and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the ...

November 2013 35 pages

2014 Analysis of Leading Microbiology Market Players--Insightful Profiles of Major Suppliers and Recent Market Entrants

US$ 1,960.00

This new 90-page report from Venture Planning Group provides insightful profiles of leading microbiology market players and recent market entrants. The report presents strategic assessments, including sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative ...

November 2013 90 pages

2014 Strategic Analysis of Major Blood Banking Product Suppliers

US$ 1,960.00

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, ...

November 2013 50 pages

2014 analysis of the Global Enteric Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers

US$ 9,200.00

... -page report from Venture Planning Group contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, ... of leading suppliers. About This Report This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, ...

November 2013 389 pages

2014 Analysis of the Global Respiratory Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players

US$ 7,880.00

... report from Venture Planning Group contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, ... of leading suppliers. About This Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, ...

November 2013 366 pages

2014 Analysis of the Global Sexually-Transmitted Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review,Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players

US$ 7,680.00

... page report from Venture Planning Group contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging ... , and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain ...

November 2013 350 pages

Filters

Search

Categories

3
6
249
2
165
164
52
726
612
487
422
365
289
206
808
227
226
183
47
33
17
17
15
14
10
8
7
5
4
3
2
2
2
1
1
2
5
1,360
40
576
38,287
43
8
15
2
1,289
1,108
237
1,201
134
97
1
69
3
53
631
6
932
21
6
1
253
3,934
324
1
644
585
228
219
202
93
69
35
17
15
812
27
333
85
11
1
1
550
20
108

Publishers

60,074

Regions

16
1
137
135
134
134
134
138
138
137
137
137
137
137
137
136
136
136
135
134
131
130
175
194
193
15
104
194
5
174
197
196
195
195
194
194
194
194
194
194
194
194
193
193
193
193
193
192
192
192
192
192
191
191
191
137
137
4
3
2
201
201
198
198
198
197
197
197
197
196
196
196
196
196
196
196
196
195
195
194
194
194
194
194
193
192
191
191
190
188
187
110
107
107
106
106
1,143
201
197
33,414
1,610
1,253
1,251
1,245
1,228
1,218
1,196
401
200

Price

Date

Pages

Offers